Anixa Biosciences, Inc. ANIX on Monday provided an update on patient outcomes observed in its ongoing Phase 1 ovarian cancer ...
Phase 2 trial of trastuzumab and/or everolimus in hormone-resistant HER2-negative metastatic breast cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin administration during in vitro fertilization than women without PCOS, according to data from ...
The synthesis of follicle-stimulating hormone (FSH) in pituitary gonadotrope cells is a tightly controlled process that integrates multiple endocrine and paracrine signals. Central to this regulation ...
Follicle-stimulating hormone receptor (FSHR) N680S–genotyped women treated with either recombinant FSH or urinary FSH had higher pregnancy rates of 51% vs 40% in non-genotyped control individuals.
ROCKVILLE, Md.--(BUSINESS WIRE)-- Trophogen Inc., a biotechnology company developing hormone and related growth factor analogs for human infertility, animal superovulation, and human cancers together ...
Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results